Nisha Nanda
Director/Board Member at MORPHIC HOLDING, INC.
Net worth: - $ as of 2024-04-29
Profile
Nisha Nanda is an Independent Director at Morphic Holding, Inc. She previously worked as a Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014.
She then served as the Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023.
Dr. Nanda holds undergraduate and doctorate degrees from The University of New South Wales.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
-.--% | 2024-03-31 | 0 ( -.--% ) | - $ | 2024-04-29 |
Nisha Nanda active positions
| Companies | Position | Start |
|---|---|---|
| MORPHIC HOLDING, INC. | Director/Board Member | 2021-08-18 |
Former positions of Nisha Nanda
| Companies | Position | End |
|---|---|---|
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 2023-04-30 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2014-01-31 |
Training of Nisha Nanda
| The University of New South Wales | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Nisha Nanda
